- SENIOR FACULTY Otolaryngology
- Basal Cell Carcinoma
- Laryngeal Cancer
- Melanoma Removal
- Needle Biopsy: Thyroid
- Nontoxic Nodular Goiter
- Robot-Assisted Surgery - Overview
- Salivary Glands
- Skin Lesion Removal
- Squamous Cell Carcinoma
- Throat Cancer
- Thyroid Cancer
- Tongue Cancer
- Tonsil Cancer
MD, Yale University School of Medicine
Stanford University Hospital
Fellowship, Head & Neck Surgery
MD Anderson Cancer Center (Univ of Texas)
Dr. Mike Yao is a fellowship trained head and neck surgical oncologist. A graduate of the University of California, Berkeley, Dr. Yao went to Yale University, School of Medicine. He did his residency in Otolaryngology at Stanford University and completed a Head and Neck Surgical Oncology Fellowship at the MD Anderson Cancer Center in Houston, TX.
After completing his fellowship, Dr. Yao joined the faculty at the University of Illinois at Chicago, where he rose to the rank of Associate Professor and served as program director of the residency program. In 2008, he joined the faculty at Stanford University where he specialized in care of patients with melanoma of the head and neck. In 2011, he moved to Westchester County, NY and was in practice at Westchester Medical Center. He joined the practice at Mount Sinai in 2014.
Dr. Yao cares for patients with head and neck cancer. He has a special interest in diseases of the thyroid and parathyroid, melanoma and advanced skin cancers.
Dr. Yao has over 30 publications and been invited to lecture nationally and internationally over 90 times. He has been named to the Best Doctors and America’s Top Doctors numerous times.
Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE, Sunwoo JB, Sirjani D, Hara W, Yao M. Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer 2013 Apr; 119(7).
Yao M, Roebuck JC, Holsinger FC, Myers JN. Elective neck dissection during salvage laryngectomy. American journal of otolaryngology; 26(6).
Agulnik M, Rhee EN, Yao M, Mundt AJ, Feldman LE. Paclitaxel, carboplatin, and concomitant radiotherapy for resected patients with high risk head and neck cancer. Journal of chemotherapy (Florence, Italy) 2005 Apr; 17(2).
Hall CL, Yao M, Hill LL, Owen-Schaub LB. Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice. Clinical & experimental metastasis 2004; 21(3).
Saeed S, Yao M, Philip B, Blend M. Localizing hyperfunctioning parathyroid tissue: MRI or nuclear study or both?. Clinical imaging; 30(4).
Ho AS, Kaplan MJ, Fee WE, Yao M, Sunwoo JB, Hwang PH. Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. International forum of allergy & rhinology; 2(2).
Kolokythas A, Schwartz JL, Pytynia KB, Panda S, Yao M, Homann B, Sroussi HY, Epstein JB, Gordon SC, Adami GR. Analysis of RNA from brush cytology detects changes in B2M, CYP1B1 and KRT17 levels with OSCC in tobacco users. Oral oncology 2011 Jun; 47(6).
Klasser GD, Epstein JB, Utsman R, Yao M, Nguyen PH. Parotid gland squamous cell carcinoma invading the temporomandibular joint. Journal of the American Dental Association (1939) 2009 Aug; 140(8).
Mohyuddin N, Yao M. Primary intraosseous carcinoma of the anterior maxilla: an unusual case and review of the literature. Ear, nose, & throat journal 2011 May; 90(5).
Rubinstein PG, Lindgren V, Setty S, Yao M, Pytynia KB, Radosevich JA, Kadkol SS, Feldman LE. Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Mar; 29(9).
Yao M, Epstein JB, Modi BJ, Pytynia KB, Mundt AJ, Feldman LE. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral oncology 2007 Mar; 43(3).
Modi BJ, Knab B, Feldman LE, Mundt AJ, Yao M, Pytynia KB, Epstein J. Review of current treatment practices for carcinoma of the head and neck. Expert opinion on pharmacotherapy 2005 Jun; 6(7).
Cabay RJ, Setty S, Schwartz JL, Yao M, Schmidt ML, Gordon SC. Pediatric squamous cell carcinoma arising in an alpha-fetoprotein-producing mature cystic teratoma of the mandible. Pediatric blood & cancer 2009 Jan; 52(1).
Ahuja G, Cuellar S, Choudhry I, Setty S, Yao M, Villano JL. Complete response of CNS-involved olfactory neuroendocrine tumor using multimodal therapy. Onkologie 2008 Mar; 31(3).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Yao did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Hess CSM Building Floor 3rd
1470 Madison Avenue
New York, NY 10029